Literature DB >> 15489290

Elongation by RNA polymerase II: the short and long of it.

Robert J Sims1, Rimma Belotserkovskaya, Danny Reinberg.   

Abstract

Appreciable advances into the process of transcript elongation by RNA polymerase II (RNAP II) have identified this stage as a dynamic and highly regulated step of the transcription cycle. Here, we discuss the many factors that regulate the elongation stage of transcription. Our discussion includes the classical elongation factors that modulate the activity of RNAP II, and the more recently identified factors that facilitate elongation on chromatin templates. Additionally, we discuss the factors that associate with RNAP II, but do not modulate its catalytic activity. Elongation is highlighted as a central process that coordinates multiple stages in mRNA biogenesis and maturation.

Mesh:

Substances:

Year:  2004        PMID: 15489290     DOI: 10.1101/gad.1235904

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  352 in total

1.  The Influence of Look-Ahead on the Error Rate of Transcription.

Authors:  Y R Yamada; C S Peskin
Journal:  Math Model Nat Phenom       Date:  2010-01-27       Impact factor: 4.157

Review 2.  RNA polymerase II elongation control.

Authors:  Qiang Zhou; Tiandao Li; David H Price
Journal:  Annu Rev Biochem       Date:  2012-03-09       Impact factor: 23.643

3.  Ssu72 phosphatase-dependent erasure of phospho-Ser7 marks on the RNA polymerase II C-terminal domain is essential for viability and transcription termination.

Authors:  David W Zhang; Amber L Mosley; Sreenivasa R Ramisetty; Juan B Rodríguez-Molina; Michael P Washburn; Aseem Z Ansari
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

4.  Proteomic analysis of mitotic RNA polymerase II reveals novel interactors and association with proteins dysfunctional in disease.

Authors:  André Möller; Sheila Q Xie; Fabian Hosp; Benjamin Lang; Hemali P Phatnani; Sonya James; Francisco Ramirez; Gayle B Collin; Jürgen K Naggert; M Madan Babu; Arno L Greenleaf; Matthias Selbach; Ana Pombo
Journal:  Mol Cell Proteomics       Date:  2011-12-22       Impact factor: 5.911

Review 5.  Transcriptional activators and activation mechanisms.

Authors:  Jun Ma
Journal:  Protein Cell       Date:  2011-12-17       Impact factor: 14.870

6.  The general transcription factor TAF7 is essential for embryonic development but not essential for the survival or differentiation of mature T cells.

Authors:  Anne Gegonne; Xuguang Tai; Jinghui Zhang; Gang Wu; Jianjian Zhu; Aki Yoshimoto; Jeffrey Hanson; Constance Cultraro; Qing-Rong Chen; Terry Guinter; Zhihui Yang; Karen Hathcock; Alfred Singer; Jaime Rodriguez-Canales; Lino Tessarollo; Susan Mackem; Daoud Meerzaman; Ken Buetow; Dinah S Singer
Journal:  Mol Cell Biol       Date:  2012-03-12       Impact factor: 4.272

7.  Targeting MYC dependence in cancer by inhibiting BET bromodomains.

Authors:  Jennifer A Mertz; Andrew R Conery; Barbara M Bryant; Peter Sandy; Srividya Balasubramanian; Deanna A Mele; Louise Bergeron; Robert J Sims
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

8.  Activator-dependent p300 acetylation of chromatin in vitro: enhancement of transcription by disruption of repressive nucleosome-nucleosome interactions.

Authors:  Heather J Szerlong; Jessica E Prenni; Jennifer K Nyborg; Jeffrey C Hansen
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

9.  RNA polymerase is poised for activation across the genome.

Authors:  Ginger W Muse; Daniel A Gilchrist; Sergei Nechaev; Ruchir Shah; Joel S Parker; Sherry F Grissom; Julia Zeitlinger; Karen Adelman
Journal:  Nat Genet       Date:  2007-11-11       Impact factor: 38.330

10.  Missense variants in the chromatin remodeler CHD1 are associated with neurodevelopmental disability.

Authors:  Genay O Pilarowski; Hilary J Vernon; Carolyn D Applegate; Leandros Boukas; Megan T Cho; Christina A Gurnett; Paul J Benke; Erin Beaver; Jennifer M Heeley; Livija Medne; Ian D Krantz; Meron Azage; Dmitriy Niyazov; Lindsay B Henderson; Ingrid M Wentzensen; Berivan Baskin; Maria J Guillen Sacoto; Gregory D Bowman; Hans T Bjornsson
Journal:  J Med Genet       Date:  2017-09-02       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.